HFA Premium Access

Quality of life is similar in patients with chronic stable heart failure on vasodilating and non-vasodilating beta blockers.

Congress Session

About the speaker

Doctor Rebabonye Pharithi

Heart Failure Unit, St Vincent University Hospital Group, Dublin (Ireland)
0 follower

5 more presentations in this session

Increase of beta-blocker dose and QT interval in heart failure - do we really know it all by heart? Results from CIBIS ELD study.

Speaker: Professor S. Apostolovic (Nis, RS)

Thumbnail

Beneficial effects of beta-blockers and ivabradine combination in patients hospitalized due to worsening of heart failure: findings from

Speaker: Professor Y. Lopatin (Volgograd, RU)

Thumbnail

Are beta-blockers effective in children with congestive heart failure? - A Cochrane review

Speaker: Doctor S. Alabed (Sheffield, GB)

Thumbnail

The impact of 12 month beta-blocker therapy on left and right ventricular volumes and ejection fraction and functional status of heart failure patients with midrange ejection fraction

Speaker: Professor M. Poltavskaya (Moscow, RU)

Thumbnail

Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure

Speaker: Doctor H. Froehlich (Heidelberg, DE)

Thumbnail

Access the full session

Poster Session 2 - Beta blockers

Speakers: Doctor R. Pharithi, Professor S. Apostolovic, Professor Y. Lopatin, Doctor S. Alabed, Professor M. Poltavskaya...
Thumbnail

About the event

Image

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk